Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonisamide and Methylprednisolone for Prevention of Noise-induced Hearing Loss
NCT02049073Phase 2Withdrawn
- Sponsor
- Washington University School of Medicine
- Start
- Oct 2017
- Primary completion
- Nov 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of zonisamide, methylprednisolone in noise-induced hearing loss (NIHL), sponsored by Washington University School of Medicine. Planned start Oct 2017; status: withdrawn.
02
Drugs
zonisamidemethylprednisolone
03
Conditions
noise-induced hearing loss (NIHL)
Beyond the preview
Go deeper on NCT02049073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02049073.